… The purpose of this Perspective article is to discuss these deficiencies to highlight future
directions of research in the field of adenosine receptor-mediated protection of ischemic …

… current scientific evidence that may help to identify possible phenotypes or subgroups of
responders to β 2 -AR agonist … be the starting point for future targeted randomised clinical trials …

… β 2 -agonists are notably present. Increasing amounts of evidence have unveiled the alternative
mechanisms of the β 2 -AR agonists … Future clinical trials focusing on the renal outcome, …

… Functional CaSRs are present in adult human ASM and regulate basal and agonist-induced
[Ca 2+ ] i , as well as contractility [74]. CaSRs are upregulated and constitutively activated in …

… trends over time in the use of newly introduced β2-agonists … for covariates that were present
only before cohort entry to … β-antagonists and β2-agonists only if they were present at least 2, …

… Compound 2a was used in a recent study to evaluate its effects on agonist-induced μ-opioid
receptor (MOPr) desensitization in locus coeruleus neurons. (100) In HEK 293 cells, 2a …

… C-1 hydroxy group that is present in most β2-adrenoceptor agonists, but has incorporated
a … or twice-daily doses will address unresolved questions in future and current clinical trials. …

… the symptoms and prognosis of COPD patients in the future. … In this review, we discuss and
update recent research on β2-… Also, the precision diagnosis will provide us another direction …

… In this prospective study of the Norwegian population, we estimated the incidence of …
Adjusting for level of education in the present study did not notably influence the risk estimates …

Introduction: A fixed-dose inhalation of a long-acting β-agonist (LABA) and inhaled
corticosteroids (ICS) is commonly recommended for moderate to severe asthmatic patients not …